Editorial
doi: 10.1200/JCO.2015.63.3628.
Epub 2015 Aug 31.
Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity
Affiliations
- PMID: 26324366
- DOI: 10.1200/JCO.2015.63.3628
Item in Clipboard
Editorial
Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity
J Clin Oncol.
.
No abstract available
Comment on
-
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.J Clin Oncol. 2015 Nov 1;33(31):3660-7. doi: 10.1200/JCO.2015.63.0996. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324357
Similar articles
-
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.J Clin Oncol. 2015 Nov 1;33(31):3660-7. doi: 10.1200/JCO.2015.63.0996. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324357
-
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.J Clin Oncol. 2010 Feb 10;28(5):893-901. doi: 10.1200/JCO.2009.27.0660. Epub 2010 Jan 11. J Clin Oncol. 2010. PMID: 20065170 Review. No abstract available.
-
Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology.J Clin Oncol. 2013 May 20;31(15):1842-8. doi: 10.1200/JCO.2012.45.2789. Epub 2013 Apr 15. J Clin Oncol. 2013. PMID: 23589552 Review.
-
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11. J Clin Oncol. 2003. PMID: 12692171
-
Legislation on genetic testing and the practice of oncology.Crit Rev Oncol Hematol. 2009 Feb;69(2):95-7. doi: 10.1016/j.critrevonc.2008.10.002. Epub 2008 Nov 6. Crit Rev Oncol Hematol. 2009. PMID: 18993081 No abstract available.
Cited by
-
Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives.Front Oncol. 2024 Jul 11;14:1387345. doi: 10.3389/fonc.2024.1387345. eCollection 2024. Front Oncol. 2024. PMID: 39055566 Free PMC article. Review.
-
CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.Eur Radiol Exp. 2023 Nov 2;7(1):64. doi: 10.1186/s41747-023-00380-7. Eur Radiol Exp. 2023. PMID: 37914925 Free PMC article.
-
Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer.Front Oncol. 2023 Mar 31;13:1064487. doi: 10.3389/fonc.2023.1064487. eCollection 2023. Front Oncol. 2023. PMID: 37064089 Free PMC article.
-
Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non-small-cell lung cancer with an EGFR/TP53 co-mutation.BMC Cancer. 2022 Dec 12;22(1):1295. doi: 10.1186/s12885-022-10391-z. BMC Cancer. 2022. PMID: 36503478 Free PMC article.
-
Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer.Cells. 2022 Sep 14;11(18):2871. doi: 10.3390/cells11182871. Cells. 2022. PMID: 36139444 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
